The United Kingdom is witnessing a noticeable surge in interest surrounding entheogenic substances. Beyond the well-established use of psilocybin and LSD, scientists and explorers are increasingly delving into less-charted territories, particularly the copyright compound and the budding cannabinoid, cannabigerol. This expanding scene encompasses cl